No Detail Found!

Efficacy and safety of 100mg/ml tranexamic acid mesotherapy for the treatment of melasma

Author(s)
Ayesha Zahir Department of Dermatology, Dow University Hospital Ojha,Karachi,Pakistan
Sadaf Ahmed Asim Department of Dermatology, Dow University Hospital Ojha,Karachi,Pakistan
Madiha Sajid Department of Dermatology, Dow University Hospital Ojha,Karachi,Pakistan
Tayyaba Iqbal Department of Dermatology, Dow University Hospital Ojha,Karachi,Pakistan
Ruba Khan Department of Dermatology, Dow University Hospital Ojha,Karachi,Pakistan
Sharmin Nasir Department of Dermatology, Dow University Hospital Ojha,Karachi,Pakistan
Abstract
Objective: To determine the efficacy and safety of 100 mg/ml intradermal tranexamic acid for the treatment of melasma. Methodology: The study was conducted at Department of Dermatology, Dow University Hospital, Ojha campus, Karachi from 1st September 2023 to 29th February 2024 and included 60 patients selected by nonprobability consecutive sampling technique. All diagnosed patients of melasma were included in the study. A detailed demographic and medical history were taken along with the Wood's lamp examination. We administered 100mg/ml tranexamic undiluted injection intradermally at the site of melasma. A total of six sessions were carried out every 2 weeks for 3 months. Modified Melasma Area and Severity Index (mMASI) score was calculated on the first and last visit to evaluate efficacy of treatment. Results: At first visit mean of mMASI was 6.43±3.57 (range 1.2-18.0), which showed significant reduction to 3.94±2.74 (range 0.3-13.8) at last visit (p<0.001). Effi-cacy of intradermal tranexamic acid was excellent in 8 (13.3%) patients, good in 10 (16.7%), fair in 33 (55.0%) and poor in 9 (15.0%) patients. Temporary redness, pain and localized bumps were noted as temporary side effe-cts. Conclusion: Higher dose of intradermal tranexamic acid (100mg/ml) was a safe and effective therapy for the treatment of melasma.
Publication Details
Page(s) 704-707
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 50, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Melasma, Melasma, Tranexamic acid., mesotherapy
References
Iqbal T,Asim SA,Sajid M,Hafeez S,Mansoor M,Mirza R .2021 .Evaluate the efficacy of intradermal tranexamic acid in melasma. Professional Med J, 28 : 350-4.
Yalamanchili R,Shastry V,Betkerur J .2015 .Clinico-epidemiological Study and Quality of Life Assessment in Melasma. Indian J Dermatol, 60 : 519.
Sarkar R,Arora P,Garg VK,Sonthalia S,Gokhale N. .2014 .Melasma update. Indian Dermatol Online J, 5 : 426-35.
Handel AC,Miot LDB,Miot HA .2014 .Melasma: a clinical and epidemiological review. An Bras Dermatol, 89 : 771-82.
Kaleem S,Ghafoor R .2020 .Comparison of efficacy of tranexamic acid mesotherapy versus 0.9% normal saline for melasma; a split face study in a tertiary care hospital of Karachi. Pak J Med Sci, 36 : 930-4.
Ogbechie-Godec OA,Elbuluk N. .2017 .Melasma: an up-to-date comprehensive review. Dermatol Ther, 7 : 305-18.
Samanthula HKM,Chowdary NKA .2020 .A study of intradermal tranexamic acid for treatment in melasma patients. Int J Res Dermatol, 6 : 632-6.
Sirithanabadeekul P,Dannarongchai A,Suwanchinda A .2020 .Platelet-rich plasma treatment for melasma: a pilot study. J Cosmet Dermatol, 19 : 1321-7.
Nijor T. .1979 .Treatment of melasma with tranexamic acid. Clin Res, 13 : 3129-31.
Basit H,Godse KV,Island (FL): StatPearls Publishing KV .2022 .. Al Aboud AM. Melasma. [Updated 2022 Aug, 8 : .
Zubair R,Lyons AB,Vellaichamy G,Peacock A,Hamzavi I. .2019 .What's New in Pigmentary Disorders. Dermatol Clin, 37 : 175-81.
McKesey J,Tovar-Garza A,Pandya AG .2020 .Melasma treatment: an evidence-based review. Am J Clin Dermatol, 21 : 173-225.
Neagu N,Conforti C,Agozzino M,Marangi GF,Morariu SH,Pellacani G .2022 .Melasma treatment: a systematic review. J Dermatol Treat, 33 : 1816-37.
Bala HR,Lee S,Wong C,Pandya AG,Rodrigues M. .2018 .Oral tranexamic acid for the treatment of melasma: a review. Dermatol Surg, 44 : 814-25.
Sharma R,Mahajan VK,Mehta KS,Chauhan PS,Rawat R,Shiny TN .2017 .Therapeutic efficacy, and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Clin Exp Dermatol, 42 : 728-34.
Budamakuntla L,Loganathan E,Suresh DH,Shanmugam S,Suryanarayan S,Dongare A .2013 .A randomized, openlabel, comparative study of tranexamic acid microinjections and tranexamic acid with micro needling in patients with melasma. J Cutan Aesthet Surg, 6 : 139-43.
Pazyar N,Yaghoobi R,Zeynalie M,Vala S M .2019 .Comparison of the efficacy of intradermal injected tranexamic acid vs hydroquinone cream in the treatment of melasma. Clin Cosmet Investig Dermatol, 12 : 115-22.
Chowdhary B,Mahajan VK,Mehta KS,Chauhan PS,Sharma V,Sharma A .2021 .Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study. Arch Dermatol Res, 313 : 109-17.
Lee HC,Thng TG,Goh CL .2016 .Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol, 75 : 385-92.
0

Citations

0

Downloads

73

Views